Ideal Medical Technologies Inc.

Asheville, NC · Founded 2014 · Medtech · Private

FUSION, a closed-loop artificial pancreas system that autonomously monitors blood glucose and infuses insulin/dextrose to maintain glucose levels in ICU patients

Claim this profile

Follows are private to you and power your alerts

Updated · idealmedical.com

Sector
Medtech
Headquarters
Asheville, NC
Founded
2014
Latest Form D
$200K, Jun 2020
Total capital
$4.1M
Federal grants
$3.8M
3 awards · 2022–2023
Rank in peer group#94 of 477
Private capital raised
$300K
2 Form D · last Jun 2020
77 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
1 pending

Capital timeline

20152017201920212023FEDERAL ↑EQUITY ↓Cumulative $4.1M$958K$1.9M$931K1st Form D$100K2nd Form D$200K
20152017201920212023FEDERAL ↑EQUITY ↓Cumulative $4.1M$958K$1.9M1st Form D$100K2nd Form D$200K

Latest events

  • Federal grantHealth and Human S · Phase II · Demonstration of the Feasibility of Closed Loop Control of Blood Glucose in the Intensive Care Unit Setting Using a Novel Artificial Intelligence Based Glucose Control System$931K
  • Federal grantHealth and Human S · Phase II · Demonstration of the Feasibility of Closed Loop Control of Blood Glucose in the Intensive Care Unit Setting Using a Novel Artificial Intelligence Based Glucose Control System$1.9M
  • Federal grantHealth and Human S · Phase II · Demonstration of the Feasibility of Closed Loop Control of Blood Glucose in the Intensive Care Unit Setting Using a Novel Artificial Intelligence Based Glucose Control System$958K
  • Private capital raisedForm D · SEC · 2nd filing$200K
  • Private capital raisedForm D · SEC · 1st filing$100K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 477 peers

Line = median

Medtech · Device

  • Federal grants#94 · top 20%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Leon DeJournettResearcherExecutive Officer, DirectorLinked by $3.8M in grants as PI

What it has protected

USPTO · 0 granted of 1
  • PendingComputerized System For Blood Chemistry MonitoringUSPTOApplication 14623787
  • Veriskin, Inc.Similar federal contract value in Medtech · null in contracts
  • TAUVISION, INC.Similar federal contract value in Medtech · null in contracts
  • Kneevoice, Inc.Similar federal contract value in Medtech · null in contracts
  • NASONI LLCSimilar federal contract value in Medtech · null in contracts
  • ORTHOPRESERVE, INC.Similar federal contract value in Medtech · null in contracts
  • APERTURE BIO, INC.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .